Clinical trial
Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer
NCT00060372
Study timeline
Study start (unknown)2003-04-01Date precision: month
Registry last updated2013-03-27
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Childhood Myelodysplastic Syndromesunresolved
Disseminated Neuroblastomaunresolved
Malignant Neoplasmunresolved
Ovarian Choriocarcinomaunresolved
Ovarian Embryonal Carcinomaunresolved
Ovarian Immature Teratomaunresolved
Ovarian Mature Teratomaunresolved
Ovarian Mixed Germ Cell Tumorunresolved
Ovarian Polyembryomaunresolved
Ovarian Yolk Sac Tumorunresolved
Recurrent Adult Acute Myeloid Leukemiaunresolved
Recurrent Adult Burkitt Lymphomaunresolved
Recurrent Adult Hodgkin Lymphomaunresolved
Recurrent Adult Lymphoblastic Lymphomaunresolved
Recurrent Grade 3 Follicular Lymphomaunresolved
Recurrent Mantle Cell Lymphomaunresolved
Recurrent Neuroblastomaunresolved
Recurrent Ovarian Epithelial Cancerunresolved
Recurrent Ovarian Germ Cell Tumorunresolved
Refractory Chronic Lymphocytic Leukemiaunresolved
Refractory Multiple Myelomaunresolved
Relapsing Chronic Myelogenous Leukemiaunresolved
Stage I Multiple Myelomaunresolved
Stage II Multiple Myelomaunresolved
Stage II Ovarian Epithelial Cancerunresolved
Stage III Multiple Myelomaunresolved
Stage III Ovarian Epithelial Cancerunresolved
Stage IIIA Breast Cancerunresolved
Stage IIIB Breast Cancerunresolved
Stage IIIC Breast Cancerunresolved
Stage IV Breast Cancerunresolved
Stage IV Ovarian Epithelial Cancerunresolved
Testicular Choriocarcinomaunresolved
Testicular Choriocarcinoma and Seminomaunresolved
Testicular Choriocarcinoma and Teratomaunresolved
Testicular Embryonal Carcinomaunresolved
Testicular Teratomaunresolved
Testicular Yolk Sac Tumorunresolved
Testicular Yolk Sac Tumor and Teratomaunresolved
Interventions
ipilimumabDRUG · verified · RxNorm: ipilimumab
Sponsors & collaborators
National Cancer Institute (NCI)lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00060372 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.